Lei Yunshang Group promotes the rapid development of enterprises with scientific and technological innovation, develops innovative Chinese medicine research and development around major diseases, and builds a research and development platform for compound Chinese medicine, component Chinese medicine and secondary development of products - Lei Yun Shang Chinese Medicine Research Institute. At present, the institute has more than 70 team members, covering various majors such as Chinese pharmacy, pharmacy, biopharmaceutical, pharmaceutical analysis, and traditional Chinese medicine.
The Institute of Traditional Chinese Medicine has been identified as a key enterprise R&D institution in Jiangsu Province, Jiangsu Provincial Traditional Chinese Medicine Solid Preparation Engineering Technology Research Center, Suzhou Traditional Chinese Medicine Engineering Technology Research Center, and Suzhou Key Laboratory of Chinese Medicine Pellets Preparation Research. The institute now has large-scale detection instruments such as high performance liquid chromatography, atomic absorption spectrophotometer, gas chromatograph, near-infrared spectroscopy analyzer, TOC total organic carbon analyzer, and a complete set of pilot research equipment for Chinese medicine extraction and refining system, and Chinese medicine extraction. Automated control system, etc., with complete infrastructure, advanced domestic drug development and technological innovation capabilities.
The Institute has carried out scientific research cooperation with famous universities such as Peking University, Zhejiang University, Suzhou University, China Pharmaceutical University, Jiangsu Provincial Institute of Traditional Chinese Medicine, Guangzhou Medical University, Shenyang Pharmaceutical University, China Academy of Chinese Medical Sciences and Nanjing University of Traditional Chinese Medicine. . Established the Chinese Medicine Quality Control Technology Laboratory with Zhejiang University, and established the Lei Yunshang New Drug Research and Development Center in cooperation with Jiangsu Academy of Traditional Chinese Medicine. It cooperated with Suzhou University and Nanjing University of Traditional Chinese Medicine to build a graduate student workstation in Jiangsu Province.
The Institute of Traditional Chinese Medicine has successfully developed a number of traditional Chinese medicines such as Xiaoyue Pill, Tianzhu Capsule, Liushen Gel, Liushen Capsule, Kuhuang Granule, and Huangqi Yishen Capsule. It has 3 national Chinese medicine protection varieties and 5 high-tech products from Jiangsu Province. . He has obtained 19 invention patents and applied for 9 invention patents. Among them, Xiaoyue Pill, Liushen Pill and Tianfoshen Oral Liquid were selected as the scientific and technological achievements transformation project of Jiangsu Province. Kuhuang Injection was awarded the “Jiangsu Province Science and Technology Progress Award”, and Xiaoshi Pills Tiansheng was awarded the Suzhou Science and Technology in 2016. The second prize of the Progressive Elimination Pills won the first prize of Jiangsu Traditional Chinese Medicine Science and Technology in 2019.
In the past three years, the Institute has undertaken 7 national, provincial and municipal science and technology projects, including the Xiaozheng Pill National Torch Program, the Suzhou Enterprise (2015-2017) Technology Innovation Capability Comprehensive Improvement Program, and the “Anti-Mammary Hyperplasia Chinese Medicine”. The research and development and industrialization of Xinyao Xiaozheng Pills The special fund project for the transformation of scientific and technological achievements in Jiangsu Province has passed the acceptance test. 4 research projects in science and technology: State Administration of Traditional Chinese Medicine, National Development and Reform Commission, Liushenmao National Traditional Chinese Medicine Standardization Project, Liushenmao Provincial Science and Technology Achievements Transformation Special Fund Project, Liushen Pill Automated Production Line Technical Transformation Project, and 2018 National Key Research and Development Program--Traditional Chinese Medicine Modernization Research 2018 Key special items (research on the key technology of (oral) dosage form design and formulation prescription optimization of drug materials in the base drug).
In the past 300 years, Lei Yunshang has passed on the wisdom of health. Lei Yishang Group Chinese Medicine Research Institute will always adhere to the concept of “technology is the driving force of development”, based on “research and development”, “patient as the core” and “market-oriented”. ", strive to promote technological innovation, inherit the classics, and innovate the future."